Announcements Trials
Browse Landscape

Phase

Phase 2 112Phase 1 25Phase 3 22Phase 1/2 21Phase NA 4Phase 4 3Phase 2/3 3

Status

Completed 3Unknown 2Terminated 2

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 2Caucasian Patients With EGFR Mutation Positive Advanced NSCLC 1Carcinoma 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Cisplatin 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Completed × Gefitinib × Clear all
NCT01203917 2017-01-02

IFUM

AstraZeneca

Phase 4 Completed
1,060 enrolled 14 charts
Thoracic

Caucasian Patients With EGFR Mutation Positive Advanced NSCLC

NCT00770588 2016-02-08

INFORM

AstraZeneca

Phase 4 Completed
296 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00608868 2012-09-28

SELINE

AstraZeneca

Phase 4 Completed
156 enrolled 14 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡